Medtronic Total Assets 2010-2025 | MDT
Medtronic total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Medtronic total assets for the quarter ending April 30, 2025 were $91.680B, a 1.89% increase year-over-year.
- Medtronic total assets for 2025 were $91.68B, a 1.89% increase from 2024.
- Medtronic total assets for 2024 were $89.981B, a 1.06% decline from 2023.
- Medtronic total assets for 2023 were $90.948B, a 0.04% decline from 2022.
| Medtronic Annual Total Assets (Millions of US $) |
|
|---|---|
| 2025 | $91,680 |
| 2024 | $89,981 |
| 2023 | $90,948 |
| 2022 | $90,981 |
| 2021 | $93,083 |
| 2020 | $90,689 |
| 2019 | $89,694 |
| 2018 | $91,393 |
| 2017 | $99,857 |
| 2016 | $99,644 |
| 2015 | $106,685 |
| 2014 | $37,943 |
| 2013 | $34,900 |
| 2012 | $32,818 |
| 2011 | $30,675 |
| 2010 | $28,090 |
| 2009 | $23,588 |
| Medtronic Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-04-30 | $91,680 |
| 2025-01-31 | $89,973 |
| 2024-10-31 | $90,042 |
| 2024-07-31 | $89,749 |
| 2024-04-30 | $89,981 |
| 2024-01-31 | $90,836 |
| 2023-10-31 | $90,087 |
| 2023-07-31 | $90,776 |
| 2023-04-30 | $90,948 |
| 2023-01-31 | $94,134 |
| 2022-10-31 | $93,241 |
| 2022-07-31 | $89,914 |
| 2022-04-30 | $90,981 |
| 2022-01-31 | $91,804 |
| 2021-10-31 | $91,756 |
| 2021-07-31 | $91,802 |
| 2021-04-30 | $93,083 |
| 2021-01-31 | $97,270 |
| 2020-10-31 | $95,886 |
| 2020-07-31 | $93,906 |
| 2020-04-30 | $90,689 |
| 2020-01-31 | $92,822 |
| 2019-10-31 | $91,053 |
| 2019-07-31 | $91,268 |
| 2019-04-30 | $89,694 |
| 2019-01-31 | $88,730 |
| 2018-10-31 | $88,150 |
| 2018-07-31 | $89,721 |
| 2018-04-30 | $91,393 |
| 2018-01-31 | $95,800 |
| 2017-10-31 | $94,458 |
| 2017-07-31 | $100,250 |
| 2017-04-30 | $99,857 |
| 2017-01-31 | $97,578 |
| 2016-10-31 | $98,406 |
| 2016-07-31 | $98,601 |
| 2016-04-30 | $99,644 |
| 2016-01-31 | $102,706 |
| 2015-10-31 | $104,945 |
| 2015-07-31 | $104,626 |
| 2015-04-30 | $106,685 |
| 2015-01-31 | $55,233 |
| 2014-10-31 | $38,780 |
| 2014-07-31 | $37,554 |
| 2014-04-30 | $37,943 |
| 2014-01-31 | $37,231 |
| 2013-10-31 | $36,468 |
| 2013-07-31 | $34,972 |
| 2013-04-30 | $34,900 |
| 2013-01-31 | $34,949 |
| 2012-10-31 | $33,960 |
| 2012-07-31 | $33,252 |
| 2012-04-30 | $32,818 |
| 2012-01-31 | $31,911 |
| 2011-10-31 | $31,753 |
| 2011-07-31 | $31,091 |
| 2011-04-30 | $30,675 |
| 2011-01-31 | $30,597 |
| 2010-10-31 | $29,311 |
| 2010-07-31 | $28,660 |
| 2010-04-30 | $28,090 |
| 2010-01-31 | $25,168 |
| 2009-10-31 | $24,284 |
| 2009-07-31 | $23,574 |
| 2009-04-30 | $23,588 |
| 2009-01-31 | $22,764 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $113.364B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.97 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |